Introduction {#sec1_1}
============

Non-small-cell lung cancer (NSCLC) is the most common type of pulmonary cancer and accounts for 85--90% of lung cancers \[[@B1], [@B2]\]. Histological subtypes of NSCLC are adenocarcinoma (50% of cases), squamous cell carcinoma (40% of cases), large-cell carcinoma (almost 10% of cases), and rarely adenosquamous carcinoma. The most common sites of metastasis in NSCLC are the central nervous system, bones, liver, contralateral lung, adrenal glands, and lymph nodes. Almost 50% of lung cancers are metastatic at diagnosis. Rarely, NSCLC metastases have been reported in soft tissue, kidney, peritoneum, spleen, pancreas, intestine, bone marrow, eye, ovary, thyroid, heart, breast, nasal cavity, and tonsils \[[@B3]\]. Generally, metastases to the spleen from solid tumors are uncommon. The prevalence of splenic metastasis ranges from 2.3 to 7.1% for all solid cancers \[[@B4]\]. Although splenic metastasis from breast cancer, lung cancer, colorectal cancer, ovarian cancer, and melanoma (commonest site of splenic metastases per primary tumor) have been reported \[[@B4], [@B5], [@B6]\], isolated splenic metastasis from lung cancer is an extremely rare complication, and, to our knowledge, only 28 cases have been reported in the medical literature. We report the case of a 66-year-old woman with a primary isolated splenic metastasis from adenocarcinoma of the lung (NSCLC).

Case Presentation {#sec1_2}
=================

A 66-year-old woman presented in June 2016 with acute dyspnea and chest pain. A computed tomography (CT) scan revealed a right-sided lung tumor with ipsilateral enlarged mediastinal lymph nodes. Fine-needle aspiration showed moderately (G2) differentiated bronchial adenocarcinoma. A CT of the abdomen demonstrated a low-density cystic lesion in the spleen which measured 3.6 cm in diameter, in keeping with primary splenic metastasis. Therefore, the tumor was staged as cT2a cN2 cM1b. The primary tumor did not express EGFR or ALK mutations. The patient had several comorbidities, including chronic obstructive lung disease (Gold IV), obesity, diabetes mellitus type II, elevated blood pressure, and a recent episode of bilateral central pulmonary embolism. Operative removal of the primary tumor and synchronous or metachronous splenectomy were deemed impossible due to multiple comorbidities. We proceeded with combination chemoradiotherapy of the primary tumor using cisplatin and vinorelbine. We later substituted carboplatin for cisplatin due to renal insufficiency. In October 2016, after 6 courses of therapy, a follow-up CT scan demonstrated partial remission of the primary tumor and shrinkage of the splenic metastasis to a maximum diameter of 1.6 cm. Further best supportive care was offered to the patient because of her severely limited overall condition.

Discussion {#sec1_3}
==========

The reported incidence of splenic metastasis from primary lung cancer is 1.2--5.6% \[[@B7], [@B8], [@B9]\], and in this setting, splenic metastasis is mainly seen in the terminal stage as part of a diffuse metastatic process, where an average of 3--6 other organs are usually involved \[[@B7], [@B10], [@B11]\]. We found only 28 cases of isolated splenic metastasis from lung cancer in the literature (Table [1](#T1){ref-type="table"}). In these cases, a strong male predominance (58%) was recorded (patients ranging in age from 49 to 82 \[mean 62.3\] years). In most reports, the primary tumor was located in the right lung. The most common histopathological subtype of lung cancer with isolated splenic metastasis was adenocarcinoma (44% of cases), followed by squamous cell cancer (17% of cases) and large-cell lung cancer (17% of cases). Surprisingly, there is no report of isolated splenic metastasis in small-cell lung cancer, although splenic metastasis in the context of multiple metastatic sites is well recognized in small-cell lung cancer \[[@B12], [@B13], [@B14]\]. One case of carcinoid with isolated spleen deposits has been reported. Including our report, splenic metastasis was synchronous in 12 cases and metachronous in another 17 cases. In the 17 cases of metachronous isolated splenic metastasis, the median interval between the diagnosis of the primary tumor and isolated splenic metastasis was 22.2 (range 2--96) months. The majority of cases were asymptomatic (62% of cases), and the diagnosis was serendipitously made at follow-up exams. Some patients presented with splenic rupture (12% of cases), abdominal pain (21% of cases), and fever (3% of cases).

The early detection of metastasis to the spleen is challenging, since most cases of splenic metastasis are asymptomatic, and most of them are detected incidentally. CT scan of the abdomen remains the gold standard to detect splenic metastasis, including in the case of primary lung cancer. Some studies have also mentioned the significance of FDG-PET/CT in the detection of splenic metastasis from lung cancer \[[@B4], [@B6], [@B15], [@B16], [@B17]\]. By CT imaging, splenic metastases can appear in 3 patterns: (1) as a solid lesion, (2) as a cystic lesion (as in our case), and (3) as a solid-cystic lesion \[[@B7]\]. In histopathology, splenic metastases appear in 3 macroscopic patterns: macronodular, micronodular, and diffuse \[[@B6]\]. Iguchi et al. \[[@B14]\] mentioned that the micronodular and diffuse type might not be detectable on abdominal CT scan, although FDG-PET/CT may detect the diffuse type of splenic metastasis. In case of a macronodular pattern, the metastasis can either present as solitary or multiple nodules; the micronodular pattern can be diagnosed by the presence of scattered uniform miliary nodules, and in case of a diffuse pattern, the splenic parenchyma is completely occupied by tumor cells \[[@B7]\]. The rarity of splenic metastases could be explained by anatomic factors and the high-quality immunological equipment of the spleen, which ensures an inhibitory effect on the growth of metastatic cells \[[@B5]\]. The differential diagnosis of a splenic mass includes splenic metastasis, hemangioma, hamartoma, non-Hodgkin lymphoma, Hodgkin lymphoma, sarcoidosis, tuberculosis, and histoplasmosis \[[@B6]\].

The majority of patients underwent a surgical resection of the primary tumor (65% of cases). In most cases, the patients underwent a splenectomy (83% of cases). Considering the therapeutic principle of oligometastatic disease for solitary brain or adrenal metastasis, splenectomy should be considered a therapeutic option for these patients. Systemic chemotherapy after splenectomy or after double surgical resection (splenectomy followed by resection of the lung lesion or vice versa) can be considered since it can provide a prolonged progression-free survival and overall survival \[[@B4]\]. The vast majority of patients died 1--49 months after splenectomy, with rare cases of prolonged survival up to 96 months, as reported by Sardenberg et al. \[[@B6]\].
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Isolated splenic metastasis from lung cancer

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  First author \[ref.\]       Histology (primary lung lesion)                      Lung\     Time to splenic metastasis   Sex    Age, years   Metastasis symptoms   Treatment of primary tumor                     Treatment of splenic metastasis   Follow-up at the time of the report
                                                                                   lesion\                                                                                                                                                           
                                                                                   side                                                                                                                                                              
  --------------------------- ---------------------------------------------------- --------- ---------------------------- ------ ------------ --------------------- ---------------------------------------------- --------------------------------- ----------------------------------------
  Klein \[[@B18]\]            Bronchioalveolar carcinoma                           Right     20 months                    F      57           Abdominal pain        Right lower and middle lobectomy               Splenectomy                       Died 49 months after splenectomy

                                                                                                                                                                                                                                                     

  Edelman \[[@B19]\]          Poorly differentiated adenocarcinoma                 Left      0 months                     F      63           Asymptomatic          n.a.                                           n.a.                              n.a.

                                                                                                                                                                                                                                                     

  Macheers \[[@B20]\]         Large-cell undifferentiated carcinoma                Left      0 months                     n.a.   n.a.         Asymptomatic          n.a.                                           Splenectomy                       Died 1 month after splenectomy

                                                                                                                                                                                                                                                     

  Gupta \[[@B21]\]            Squamous cell carcinoma                              Right     0 months                     n.a.   n.a.         Splenic rupture       n.a.                                           Splenectomy                       Died 8 weeks after splenectomy

                                                                                                                                                                                                                                                     

  Kinoshita \[[@B9]\]         Squamous cell carcinoma                              Left      14 months                    M      72           Asymptomatic          Surgical removal of primary tumor              Splenectomy                       Died 27 months after splenectomy

                                                                                                                                                                                                                                                     

  Takada \[[@B22]\]           Bronchopulmonary carcinoid tumor                     Right     96 months                    M      49           Abdominal pain        Right upper lobectomy                          Splenectomy                       Disease free after 8 years

                                                                                                                                                                                                                                                     

  Tomaszewski \[[@B23]\]      Lung cancer                                          Left      0 months                     M      68           Asymptomatic          Upper left lobectomy                           Splenectomy                       n.a.

                                                                                                                                                                                                                                                     

  Massarweh \[[@B24]\]        Poorly differentiated adenocarcinoma                 Left      0 months                     M      68           Splenic rupture       Palliative chemotherapy                        Splenectomy                       n.a.

                                                                                                                                                                                                                                                     

  Schmidt \[[@B25]\]          Moderately differentiated adenocarcinoma             Left      25 months                    M      72           Asymptomatic          Surgical removal of primary tumor              n.a.                              Disease free after 2 years

                                                                                                                                                                                                                                                     

  Pramesh \[[@B26]\]          Squamous cell carcinoma                              Left      2 months                     M      55           Asymptomatic          Combined radiochemotherapy                     Palliative chemotherapy           n.a.

                                                                                                                                                                                                                                                     

  Lachachi \[[@B27]\]         Poorly differentiated carcinoma                      Right     0 months                     n.a.   n.a.         Splenic rupture       n.a.                                           Splenectomy                       n.a.

                                                                                                                                                                                                                                                     

  Sánchez-Romero \[[@B28]\]   Adenocarcinoma                                       Left      0 months                     M      73           Abdominal pain        Left lung resection                            Splenectomy                       n.a.

                                                                                                                                                                                                                                                     

  Van Hul \[[@B29]\]          Adenocarcinoma                                       Left      24 months                    M      67           Asymptomatic          Surgical removal of primary tumor              Splenectomy                       n.a.

                                                                                                                                                                                                                                                     

  Ando \[[@B30]\]             Squamous cell carcinoma                              Right     10 months                    M      71           Asymptomatic          Combined radiochemotherapy                     Splenectomy                       n.a.

                                                                                                                                                                                                                                                     

  Chloros \[[@B31]\]          Squamous cell carcinoma                              Right     0 months                     M      59           Asymptomatic          Surgical removal of primary tumor              Splenectomy                       n.a.

                                                                                                                                                                                                                                                     

  Tang \[[@B4]\]              Large-cell undifferentiated carcinoma                Right     4 months                     F      49           Fever                 Lobectomy of the right middle and lower lobe   Splenectomy                       n.a.

                                                                                                                                                                                                                                                     

  Scnitu \[[@B34]\]           Large-cell anaplastic carcinoma                      n.a.      0 months                     n.a.   n.a.         Asymptomatic          Pulmonary lobectomy                            Splenectomy                       Disease free after 41 months

                                                                                                                                                                                                                                                     

  Yen \[[@B15]\]              Adenocarcinoma                                       Left      24 months                    M      56           Asymptomatic          Left pneumonectomy                             Splenectomy                       n.a.

                                                                                                                                                                                                                                                     

  Fujii \[[@B16]\]            Poorly differentiated adenocarcinoma                 Left      3 months                     M      58           Asymptomatic          Left upper lobectomy                           Splenectomy                       n.a.

                                                                                                                                                                                                                                                     

  Assouline \[[@B33]\]        Large-cell undifferentiated carcinoma                Right     21 months                    M      77           Abdominal pain        Right pneumonectomy                            Splenectomy                       Disease free after 2 years

                                                                                                                                                                                                                                                     

  Oussama \[[@B35]\]          Non-small-cell lung cancer, further histology n.a.   Left      0 months                     M      58           Abdominal pain        Chemotherapy                                   Splenectomy                       n.a.

                                                                                                                                                                                                                                                     

  Eisa \[[@B36]\]             Adenocarcinoma                                       Right     0 months                     F      53           Abdominal pain        Surgical removal of primary tumor              Splenectomy                       Disease free at the time of the report

                                                                                                                                                                                                                                                     

  Belli \[[@B37]\]            Large-cell carcinoma                                 Right     60 months                    M      65           Asymptomatic          Right pneumonectomy                            n.a.                              n.a.

                                                                                                                                                                                                                                                     

  Sardenberg \[[@B6]\]        Adenocarcinoma                                       Right     7 months                     F      49           Abdominal pain        Right upper lobectomy                          Splenectomy                       Disease free after 96 months

                                                                                                                                                                                                                                                     

  Dias \[[@B32]\]             Squamous cell carcinoma                              Right     16 months                    M      82           Asymptomatic          Right bilobectomy                              Splenectomy                       Disease free after 12 months

                                                                                                                                                                                                                                                     

  Cai \[[@B7]\]               Adenocarcinoma                                       Right     17 months                    F      56           Asymptomatic          Right lower lobectomy                          Splenectomy                       n.a.

                                                                                                                                                                                                                                                     

  Soussan \[[@B17]\]          Adenocarcinoma                                       n.a.      0 months                     M      52           Asymptomatic          n.a.                                           n.a.                              n.a.

                                                                                                                                                                                                                                                     

  Iguchi \[[@B14]\]           Adenocarcinoma                                       Left      12 months                    F      63           Asymptomatic          Left lower lobectomy                           Splenectomy                       n.a.

                                                                                                                                                                                                                                                     

  Present report              Adenocarcinoma                                       Right     0 months                     F      66           Asymptomatic          Combined radiochemotherapy                     Chemotherapy                      Still alive at the time of the report
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

n.a., not available.
